These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 19607771)

  • 41. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 42. Factors associated with INR elevation and bleeding complications during Warfarin therapy.
    Wittkowsky AK
    Arch Intern Med; 2005 Mar; 165(6):703. PubMed ID: 15795354
    [No Abstract]   [Full Text] [Related]  

  • 43. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 45. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.
    Leung VW; Shalansky SJ; Lo MK; Jadusingh EA
    Ann Pharmacother; 2009 May; 43(5):875-81. PubMed ID: 19401475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keeping warfarin therapy in balance.
    Turner L
    Nursing; 2006 Nov; 36(11):43-4. PubMed ID: 17079919
    [No Abstract]   [Full Text] [Related]  

  • 50. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.
    Lee SB; Manno EM; Layton KF; Wijdicks EF
    Neurology; 2006 Oct; 67(7):1272-4. PubMed ID: 17030765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical factors influencing the sensitivity to warfarin when restarted after surgery.
    Schulman S; El Bouazzaoui B; Eikelboom JW; Zondag M
    J Intern Med; 2008 Apr; 263(4):412-9. PubMed ID: 18205763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of warfarin reversal in orthopedic trauma surgery patients.
    Tharmarajah P; Pusey J; Keeling D; Willett K
    J Orthop Trauma; 2007 Jan; 21(1):26-30. PubMed ID: 17211265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current issues in the initial phase of warfarin therapy].
    Squizzato A; Steidl L; Ageno W
    Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of warfarin-associated coagulopathy in patients with acute gastrointestinal bleeding: a cross-sectional physician survey of current practice.
    Radaelli F; Paggi S; Terruzzi V; Meucci G; Manes G; Saibeni S; Soncini M; Masci E; Conte D
    Dig Liver Dis; 2011 Jun; 43(6):444-7. PubMed ID: 21168374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage.
    Akhter M; Morotti A; Cohen AS; Chang Y; Ayres AM; Schwab K; Viswanathan A; Gurol ME; Anderson CD; Greenberg SM; Rosand J; Goldstein JN
    Intern Emerg Med; 2018 Jun; 13(4):557-565. PubMed ID: 28573379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage.
    Jeffree RL; Gordon DH; Sivasubramaniam R; Chapman A
    J Clin Neurosci; 2009 Jul; 16(7):882-5. PubMed ID: 19342242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
    Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
    Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Practical treatment of warfarin associated coagulation disorder].
    Garcia D; Crowther MA; Ageno W
    Praxis (Bern 1994); 2010 Dec; 99(25):1569-73. PubMed ID: 21157725
    [No Abstract]   [Full Text] [Related]  

  • 60. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.